Renaissance Technologies LLC 13D and 13G filings for Corcept Therapeutics Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 10:04 am Sale |
2023-12-29 | 13G | Corcept Therapeutics Incorporated CORT |
Renaissance Technologies LLC | 6,725,871 6.520% |
-563,000 (-7.72%) |
Filing |
| 2023-02-13 09:54 am Sale |
2022-12-30 | 13G | Corcept Therapeutics Incorporated CORT |
Renaissance Technologies LLC | 7,288,871 6.770% |
-734,745 (-9.16%) |
Filing |
| 2022-02-11 11:38 am Sale |
2021-12-31 | 13G | Corcept Therapeutics Incorporated CORT |
Renaissance Technologies LLC | 8,023,616 6.950% |
-1,317,880 (-14.11%) |
Filing |
| 2021-02-10 9:49 pm Purchase |
2020-12-31 | 13G | Corcept Therapeutics Incorporated CORT |
Renaissance Technologies LLC | 9,341,496 8.040% |
1,573,282 (+20.25%) |
Filing |